Effects of synephrine and β-phenethylamine on human α-adrenoceptor subtypes

Planta Medica

Volumn 76, Issue 10, 2010, Pages 981-986

  Ma, Guoyi ^a   Bavadekar, Supriya A ^b   Schaneberg, Brian T ^a   Khan, Ikhlas A ^a,b   Feller, Dennis R ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

adrenoceptors; phenethylamine; cyclic AMP; partial agonist; radioligand binding assay; synephrine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; FORSKOLIN; MEDETOMIDINE; NOREPHEDRINE; OXEDRINE; PARTIAL AGONIST; PHENETHYLAMINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN HEK293; CHO CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; NERVE ENDING; NONHUMAN; RADIOASSAY;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; FORSKOLIN; HUMANS; MEDETOMIDINE; PHENETHYLAMINES; PHENYLPROPANOLAMINE; PLANT EXTRACTS; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; STRUCTURE-ACTIVITY RELATIONSHIP; SYNEPHRINE;

CRICETULUS GRISEUS;

EID: 77954866788     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1240884     Document Type: Article

References (23)

1. Griffth R K., Johnson E A. Adrenergic drugs. Foye WO, Lemke TL, Williams DA Principles of medicinal chemistry. Baltimore Williams & Wilkins 1995 345-365
2. Kalix P. The pharmacology of psychoactive alkaloids from Ephedra and Catha. J Ethnopharmacol 1991 32 201-208
3. Hoffman B B. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists, Chapter 10. Hardman JG, Limbird LE Goodman and Gilman's pharmacological basis of therapeutics. New York McGraw Hill Publishers 2001 237
4. Chua S S., Benrimoj S I. Non-prescription sympathomimetic agents and hypertention. Med Toxicol Adverse Drug Exp 1988 3 387-414
5. Arch J R., Ainsworth A T., Cawthorne M A., Piercy V, Vennittt M V., Thody V E., Wilson C, Wilson S. Atypical -adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 1984 309 163-165
6. 3-adrenergic activation to ephedrine-induced themogenesis in humans. Int J Obes Relat Metab Disord 1995 19 678-685
7. Haller C A., Benowitz N L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing Ephedra alkaloids. N Engl J Med 2000 343 1833-1838
8. Josefson D. Herbal stimulant causes US deaths. BM J 1996 312 1378-1379
9. Trendelenburg U. Supersensitivity and subsensitivity to sympathomimetic amine. Pharmacol Rev 1963 15 225-276
10. Trendelenburg U, Gomez Alonso de la Sierra B, Muskus A. Modification by reserpine of the response of atrial pacemaker to sympathomimetic amines. J Pharmacol Exp Ther 1963 141 301-309
11. Haaz S, Fontaine K R., Cutter G, Limdi N, Perumean-Chaney S, Allison D B. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev 2006 7 79-88
12. Brown C M., McGrath J C., Midgley J M., Muir A G. B., O'Brien J W., Thonoor C M., Williams C M., Wilson V G. Activities of octopamine and synephrine stereoisomers on -adrenoceptors. Br J Pharmacol 1988 93 417-429
13. Jordan R, Midgley J M., Thonoor C M., Williams C M. -Adrenergic activities of octopamine and synephrine stereoispmers on guinea-pig atria and trachea. J Pharm Pharmacol 1987 39 752-754
14. Kim K W., Kim H D., Jung J S., Woo R S., Kim H S., Suh H W., Kim Y H., Song D K. Characterization of antidepressant-like effects of -synephrine stereoisomers. Naunyn Schmiedebergs Arch Pharmacol 2001 264 21-26
15. Starke K. A history of Naunyn-Schmiedeberg's archives of pharmacology. Naunyn Schmiedebergs Arch Pharmacol 1998 358 1-109
16. Sloviter R S., Connor J D., Drust E G. Serotonergic properties of -phenethylamine in rats. Neuropharmacology 1980 19 1071-1074
17. Sabelli H C., Javaid J I. Phenylethylamine modulation of affect: therapeutic and diagnostic implication. J Neuropsychiatry Clin Neurosci 1995 7 6-14
18. 2-adrenergic receptor subtypes. J Pharmacol Exp Ther 2007 322 214-221
19. 2-adrenoceptors. Biochem Pharmacol 2004 67 87-96
20. 50) of an enzymatic reaction. Biochem Pharmacol 1973 22 3099-3108
21. Vansal S S., Feller D R. Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol 1999 58 807-810
22. Rothman R B., Vu N, Partilla J S., Roth B L., Hufeisen S J., Compton-Toth B A., Birkes J, Young R, Glennon R A. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective action as norepinephrine transporter substrates. J Pharmacol Exp Ther 2003 307 138-145
23. Baker G B., Raiteri M, Bertollini A, Del Carmine R, Keane P E., Martin I L. Interaction of -phenethylamine with dopamine and noradrenaline in the central nervous system of the rat. J Pharm Pharmacol 1976 28 456-457